The plant, dubbed Modulus, represents an investment of approximately $600 million and is set to be fully operational by mid-2026.
The facility is designed to produce up to four vaccines or biopharmaceuticals simultaneously and can be reconfigured within days, compared to the months or years typically required for traditional plants.
The expansion supports Singapore’s efforts to strengthen its vaccine manufacturing capacity.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
